- Cannabis industry pioneer Cannabiniers will distribute treatments utilizing Invisicare®, a patented polymer delivery system
- Agreement marks continued growth for Skinvisible’s subsidiary Ovation Science Inc.
- Patented delivery technology enables improved controlled release of topically applied products
Research and development company Skinvisible, Inc. (OTCQB: SKVI) has announced that its subsidiary Ovation Science Inc. has forged a definitive license agreement with Lighthouse Strategies LLC, through its multifaceted cannabis technology and brand management company Cannabiniers, to utilize the Company’s products formulated with its patented pharmaceutical polymer in serving the U.S. cannabis market (http://cnw.fm/Pz4rQ).
The Lighthouse agreement grants the company exclusive use of Ovation’s new patented topical and transdermal formulations for improved delivery of ingredients in select markets within the United States. This latest agreement is yet another mark of Ovation’s expansion, which has included another recently signed licensing agreement granting Canopy Growth Corp. exclusive rights to Ovation’s cannabis formulations in Canada (http://cnw.fm/N8XsZ).
As part of the agreement via Lighthouse, and in cooperation with the Advocacy Research Center, Cannabiniers will distribute cannabis-based treatments utilizing Ovation’s patented technology through its national manufacturing and distribution channels. In distributing these treatments throughout the U.S., Cannabiniers will help foster the development of healthy, safe, lifestyle-centered topical and transdermal cannabis treatments that feature the added asset of accurate time-released dosing.
Cannabiniers’ goal is to standardize cannabis use and foster its integration into the daily lives of patients and consumers—something the company has achieved with its own current brands and now intends to do with Ovation’s topical products, which feature a patented and game-changing delivery technology.
These products will initially be released through Silver State Wellness and San Diego ReLeaf, which are licensed marijuana cultivators and manufacturers of infused products servicing Nevada and California. Ovation’s technology will enable these entities to offer unique topical and transdermal cannabis products that let individuals treat themselves in a comfortable and reliable way while maintaining their everyday lifestyles.
Skinvisible is an R&D company engaged in licensing its proprietary formulations made with Invisicare®, which is the company’s patented polymer delivery system that offers life-cycle management and distinctive enhancements for topically delivered products. Invisicare uniquely allows controlled release of active ingredients and the ability to hold these ingredients on the skin for extended time periods.
Ovation Science is a Canadian subsidiary of Skinvisible holding all the rights to the Company’s cannabis formulations.
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com